Silfurberg
Overview
Silfurberg is an international venture capital firm based in Reykjavík, Iceland, focusing on early-stage investments in healthcare, biotech, and other life science sectors. The firm was founded in 2002 by Friðrik Steinn Kristjánsson and Ingibjörg Jónsdóttir, who hold equal shares in the company. Silfurberg seeks investment opportunities in these fields and is actively looking for new ventures to support. The firm's investment strategy involves a thorough evaluation process, including the submission of a detailed business plan and the professional resumes of key management. Silfurberg values traits such as work ethics, integrity, track record, creativity, experience, and high energy in the teams they invest in. They prefer companies with a focused, qualified, and motivated team ready to take the company along the road to success. Additionally, Silfurberg aims to add value to its investments by being an active participant in the companies they support. Silfurberg's portfolio includes investments in early-stage companies within the healthcare, biotech, and life sciences sectors. They have a preference for companies that can defend their position in the market once established. The firm is committed to supporting innovative ventures that align with their investment focus and values.
Investment Focus
- Detailed business plan
- Professional resumes of key management
Reach Silfurberg directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Silfurberg
What sectors does Silfurberg invest in?
Silfurberg invests in Healthcare, Life Sciences and Biotech, and is based in Reykjavík, Iceland. Silfurberg is listed as a venture capital in the ConnectSafely investor database.
What stage does Silfurberg invest at?
Silfurberg backs companies at Seed and Early Stage.
Which regions does Silfurberg invest in?
Silfurberg invests across Iceland.
Last updated · Source: ConnectSafely investor database
